Phase II Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Venetoclax (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 14 Apr 2016 Status changed from not yet recruiting to recruiting.
- 10 Mar 2016 Planned initiation date changed from 1 Feb 2016 to 1 Apr 2016, according to ClinicalTrials.gov record.
- 15 Feb 2016 New trial record